Table 3 Serious adverse eventsa.

From: Prospective individual patient data meta-analysis of two randomized trials on convalescent plasma for COVID-19 outpatients

SAE category

Total

CPb

Control

(Prolongation of) hospital admission—no.c

80

37

43

Death—no.

3

1

2

Serious transfusion related adverse event—no.d

4

1

3

Life threatening transfusion reaction—no.e

2

0

2

Other AE

2

1

1

  1. aSerious adverse events (SAE) were registered in all patients that signed the informed consent form (n = 797) regardless of being transfused or not.
  2. bConvalescent plasma.
  3. cWhen a patient is hospitalized more than once, each admission is counted separately.
  4. dAny transfusion reaction associated with a plasma transfusion that was considered as a SAE.
  5. e2 patients with anaphylaxis very soon after discharge that required urgent therapy by paramedics.
Back to article page